 |
PDBsum entry 6c0s
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
6c0s
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.27
- coagulation factor XIa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Arg-|-Ala and Arg-|-Val bonds in factor IX to form factor IXa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
28:987-992
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors.
|
|
Z.Hu,
C.Wang,
W.Han,
K.A.Rossi,
J.M.Bozarth,
Y.Wu,
S.Sheriff,
J.E.Myers,
J.M.Luettgen,
D.A.Seiffert,
R.R.Wexler,
M.L.Quan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Pyridazine and pyridazinone derivatives were designed and synthesized as
coagulation factor XIa inhibitors. Potent and selective inhibitors with single
digit nanomolar affinity for factor XIa were discovered. Selected inhibitors
demonstrated moderate oral bioavailability.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |